Growth factor modulation of surface ganglioside expression in cloned neoplastic glia

Neurosci Lett. 1993 Jan 4;149(1):1-5. doi: 10.1016/0304-3940(93)90332-f.

Abstract

Cloned neoplastic astrocytes from a human glioma-derived cell line (IPSB-18) were grown in fetal calf serum (FCS)-supplemented culture medium in the presence of three growth factors. Basic fibroblast growth factor (bFGF), epidermal growth factor (EGF) but not platelet-derived growth factor (PDGF) induced an increase in the number of cells positive for the ganglioside-recognizing monoclonal antibody, A2B5. No such growth factor-mediated induction could be detected in cells maintained in plasma-derived serum (PDS)-supplemented medium. Small molecules, removed from PDS during dialysis, may, therefore, act synergistically with growth factors in the control of ganglioside synthesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Astrocytes / drug effects
  • Astrocytes / metabolism*
  • Epidermal Growth Factor / pharmacology*
  • Fibroblast Growth Factor 2 / pharmacology*
  • Fluorescent Antibody Technique
  • Gangliosides / metabolism*
  • Glioma / metabolism*
  • Glioma / pathology
  • Histocytochemistry
  • Humans
  • Platelet-Derived Growth Factor / pharmacology
  • Tumor Cells, Cultured

Substances

  • Gangliosides
  • Platelet-Derived Growth Factor
  • Fibroblast Growth Factor 2
  • Epidermal Growth Factor